Anti-neutrophil cytoplasmic antibodies (ANCAs) are antibodies against antigens in the cytoplasm of neutrophil granulocytes (the most common type of white blood cell). They are detected as a blood test in a number of autoimmune disorders, but are particularly associated with systemic vasculitis.
Types
There are two types, depending on the pattern of staining on
light microscopy:
Pathophysiology
The exact reason why people develop ANCAs is unknown. It is assumed that ANCAs act by causing release of lytic
enzymes from the white blood cells (Falk
et al 1990), causing inflammation of the blood vessel wall (
vasculitis).
History
ANCAs were originally described in Davies
et al in 1982 in
segmental necrotising glomerulonephritis, and by van der Woude
et al in
1985 in Wegener's. The Second International ANCA Workshop, held in The Netherlands in May 1989, fixed the nomenclature on perinuclear vs. cytoplasmic patterns, and the antigens MPO and PR3 were discovered in 1988 and 1989, respectively (Jennette
et al 1990).
References
- Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology. Brit Med J 1982;285:606. PMID 6297657.
- Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990;87:4115-4119. PMID 2161532.
- Jennette JC, Hoidal JR, Falk RJ. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 1990;75:2263-4. PDF (2 MB). PMID 2189509.
- van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1(8426):425-9. PMID 2857806.
Immunology | Chemical pathology | Medical tests
ANCA | Anticorps antineutrophiles cytoplasmatiques | Antineutrofiele cytoplasmatische antistoffen